Enlargement of the distance between tumor and adjacent normal tissue/organs (Organs at risk=OAR) by interventional insertion of balloon catheters RAD317

Enlargement of the distance between tumor and adjacent normal tissue/organs (Organs at risk=OAR) by interventional insertion of balloon catheters RAD317 - Balloon study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011126

Enrollment

Registered

2017-03-16

Start date

2016-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C78.5 C22.0 C22.1

Interventions

Group 1: The aim of radiation therapy is to treat the tumor effectively, while at the same time optimally protecting the surrounding healthy organs (OAR). A retrospective dosimetric data analysis of r

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indication for high-dose-rate-brachytherapy (HDR-BT) of subcapsular liver malignomas - Declaration of consent for brachytherapy and for scientific purposes - Age > 18 years, no upper age limit - no contraindications to HDR-BT of the liver

Exclusion criteria

Exclusion criteria: Contraindikations to HDR-BT of liver

Design outcomes

Primary

Measure	Time frame
Determination of the dosimetric effect of distancing subcapsular liver tumors from adjacent normal tissue/organs (organs at risk = OAR) by inserting interventional balloon catheters.	—

Secondary

Measure	Time frame
Safety	—

Countries

Germany

Contacts

Public ContactChristel Besseler

Klinik für Radiologie und Nuklearmedizin

christel.besseler@ed.ovgu.de+49-391-6713071

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026